154 related articles for article (PubMed ID: 24196792)
1. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors.
Ono T; Tanaka N; Umeno H; Chitose SI; Shin B; Aso T; On K; Hattori C; Etoh H; Kakuma T; Abe T
J Craniomaxillofac Surg; 2017 Dec; 45(12):2128-2134. PubMed ID: 29122485
[TBL] [Abstract][Full Text] [Related]
3. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.
Homma A; Oridate N; Suzuki F; Taki S; Asano T; Yoshida D; Onimaru R; Nishioka T; Shirato H; Fukuda S
Cancer; 2009 Oct; 115(20):4705-14. PubMed ID: 19634162
[TBL] [Abstract][Full Text] [Related]
4. Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.
Homma A; Mikami M; Matsuura K; Onimaru R; Yoshida D; Shinomiya H; Ohkoshi A; Hayashi R; Saito Y; Tachibana H; Shiga K; Ueda T; Uemura H; Nakamura K; Fukuda H;
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1271-1281. PubMed ID: 38008195
[TBL] [Abstract][Full Text] [Related]
5. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma.
Ebara T; Ando K; Eishima J; Suzuki M; Kawakami T; Horikoshi H; Tamaki Y
Jpn J Radiol; 2019 Jun; 37(6):494-499. PubMed ID: 30915648
[TBL] [Abstract][Full Text] [Related]
6. The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma.
Kano S; Suzuki T; Yoshida D; Tsushima N; Hamada S; Yasuda K; Uchinami Y; Aoyama H; Homma A
Int J Clin Oncol; 2023 Sep; 28(9):1121-1128. PubMed ID: 37289379
[TBL] [Abstract][Full Text] [Related]
7. Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC).
Homma A; Nakamura K; Matsuura K; Mizusawa J; Onimaru R; Fukuda H; Fujii M
Jpn J Clin Oncol; 2015 Jan; 45(1):119-22. PubMed ID: 25332419
[TBL] [Abstract][Full Text] [Related]
8. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of superselective intra-arterial infusion with concomitant radiotherapy for adenoid cystic carcinoma of the head and neck.
Homma A; Sakashita T; Hatakeyama H; Kano S; Mizumachi T; Nakamaru Y; Yoshida D; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Acta Otolaryngol; 2015 Sep; 135(9):950-4. PubMed ID: 25925195
[TBL] [Abstract][Full Text] [Related]
10. Indications for superselective intra-arterial cisplatin infusion and concomitant radiotherapy in cases of hypopharyngeal cancer.
Furusawa J; Homma A; Onimaru R; Sakashita T; Yoshida D; Hatakeyama H; Mizumachi T; Kano S; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Auris Nasus Larynx; 2015 Dec; 42(6):443-8. PubMed ID: 25933585
[TBL] [Abstract][Full Text] [Related]
11. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.
Homma A; Onimaru R; Matsuura K; Shinomiya H; Sakashita T; Shiga K; Tachibana H; Nakamura K; Mizusawa J; Kitahara H; Eba J; Fukuda H; Fujii M; Hayashi R
Head Neck; 2018 Mar; 40(3):475-484. PubMed ID: 29130565
[TBL] [Abstract][Full Text] [Related]
12. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
[TBL] [Abstract][Full Text] [Related]
13. Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
Doi H; Fujiwara M; Kitajima K; Tanooka M; Terada T; Noguchi K; Ishikura R; Kamikonya N; Yamakado K
Nagoya J Med Sci; 2018 Nov; 80(4):541-550. PubMed ID: 30587868
[TBL] [Abstract][Full Text] [Related]
14. The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2767-70. PubMed ID: 24213278
[TBL] [Abstract][Full Text] [Related]
15. Rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer.
Homma A; Furuta Y; Suzuki F; Oridate N; Hatakeyama H; Nagahashi T; Ushikoshi S; Asano T; Nishioka T; Shirato H; Fukuda S
Head Neck; 2005 Jan; 27(1):65-71. PubMed ID: 15459915
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.
Robbins KT; Kumar P; Regine WF; Wong FS; Weir AB; Flick P; Kun LE; Palmer R; Murry T; Fontanesi J; Ferguson R; Thomas R; Hartsell W; Paig CU; Salazar G; Norfleet L; Hanchett CB; Harrington V; Niell HB
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):263-71. PubMed ID: 9226312
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma.
Shiga K; Yokoyama J; Hashimoto S; Saijo S; Tateda M; Ogawa T; Watanabe M; Kobayashi T
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):1003-9. PubMed ID: 17547996
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial cisplatin with concomitant radiation for advanced hypopharyngeal cancer.
Nomura K; Takahara M; Katayama A; Kishibe K; Kunibe I; Katada A; Hayashi T; Harabuchi Y
Laryngoscope; 2013 Apr; 123(4):916-22. PubMed ID: 23280966
[TBL] [Abstract][Full Text] [Related]
19. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
